Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
3,835
+43
+1% +$5.03K 0.08% 42
2026
Q1
$456K Sell
3,792
-166
-4% -$19.2K 0.08% 37
2025
Q4
$417K Buy
3,958
+476
+14% +$44.7K 0.07% 44
2025
Q3
$292K Buy
3,482
+500
+17% +$41.2K 0.05% 56
2025
Q2
$236K Buy
+2,982
New +$237K 0.05% 63
2023
Q1
Sell
-2,050
Closed -$227K 69
2022
Q4
$227K Sell
2,050
-875
-30% -$89.4K 0.08% 58
2022
Q3
$252K Sell
2,925
-100
-3% -$8.93K 0.12% 45
2022
Q2
$284K Sell
3,025
-3,175
-51% -$281K 0.15% 45
2022
Q1
$534K Hold
6,200
0.28% 18
2021
Q4
$476K Buy
6,200
+1,100
+22% +$87.6K 0.22% 32
2021
Q3
$414K Sell
5,100
-5,192
-50% -$395K 0.19% 30
2021
Q2
$800K Buy
+10,292
New +$766K 0.54% 43

Other funds holding MRK

New World Advisors's MRK Position: Q2 2026 in Review

New World Advisors increased its Merck (MRK) stake by 1.1% in Q2 2026, buying an estimated $5.03K and bringing the position to 3,835 shares worth $493K. The position accounts for 0.08% of the portfolio, ranked #42.

New World Advisors first reported a position in MRK in Q2 2021 and has held it in 12 quarters since. The position peaked at $800K in Q2 2021. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • New World Advisors held 3,835 shares of Merck worth $493K as of Q2 2026.
  • New World Advisors bought 43 Merck shares in Q2 2026, an estimated $5.03K.
  • Merck made up 0.08% of New World Advisors's portfolio in Q2 2026, its #42 holding.
  • New World Advisors first reported a position in Merck in Q2 2021 and has held it in 12 quarters since.
  • New World Advisors's Merck position peaked at $800K in Q2 2021.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.